New User? Sign Up | Sign In

Insider Trading - PhaseBio Pharmaceuticals Inc (PHAS)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
PHAS Insider Trading Transactions for PhaseBio Pharmaceuticals Inc
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-06-18
Sale
2019-06-20
7:09 pm
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
400 $14 $5,600 416,418
(Indirect)
View
2019-07-01
Sale
2019-07-03
4:28 pm
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
2,908 $14 $40,712 415,959
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-02-27
Option Award
2019-03-01
4:44 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Ballance David James
VP
45,000 $3.15 45,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:47 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Hutson Nancy J
Director
8,900 $3.15 8,900
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:48 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Klein Peter Justin
Director
36,000 $3.15 36,000
(Direct)
View
2019-03-01
Option Award
2019-03-01
4:52 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Lee John Sang
Chief Medical Officer
100,000 $3.15 100,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
4:55 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Loewy Caroline M
Director
8,900 $3.15 8,900
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:00 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
100,000 $3.15 100,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:02 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
36,000 $3.15 36,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:03 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS van den Broek Richard
Director
22,000 $3.15 23,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:03 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS van den Broek Richard
Director
23,000 $3.15 23,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:07 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS York Michael
VP
45,000 $3.15 45,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:23 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS TUFTS LINDA
Director
36,000 $3.15 36,000
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:35 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
10% Owner
11,000 $13.23 11,000
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:36 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Hutson Nancy J
Director
11,000 $13.23 11,000
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:36 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Loewy Caroline M
Director
9,167 $13.23 9,167
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:37 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS HARRIGAN EDMUND
Director
4,583 $13.23 4,583
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:38 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS van den Broek Richard
Director
2,750 $13.23 2,750
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:39 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Klein Peter Justin
Director
11,000 $13.23 11,000
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:44 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Mukhopadhyay Bibhash
Director
11,000 $13.23 11,000
(Direct)
View
2019-05-17
Exercise
2019-05-21
6:27 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,913 $2.27 0
(Direct)
View
2019-05-17
Exercise
2019-05-21
6:27 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,131 $1.24 0
(Direct)
View
2019-05-17
Exercise
2019-05-21
6:27 pm
2016-12-03
2022-12-21
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,913 $2.27 0
(Direct)
View
2019-05-17
Exercise
2019-05-21
6:27 pm
2018-03-14
2024-03-31
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,131 $1.24 0
(Direct)
View
2019-05-22
Exercise
2019-05-24
2:22 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
15,000 $1.69 120,582
(Direct)
View
2019-05-22
Exercise
2019-05-24
2:22 pm
N/A
2026-05-12
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
15,000 $1.69 120,582
(Direct)
View
2019-08-21
Exercise
2019-08-22
7:42 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
10,000 $1.69 4,038
(Direct)
View
2019-08-21
Exercise
2019-08-22
7:42 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
5,000 $1.44 4,038
(Direct)
View
2019-08-21
Exercise
2019-08-22
7:42 pm
N/A
2026-05-12
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
10,000 $1.69 4,038
(Direct)
View
2019-08-21
Exercise
2019-08-22
7:42 pm
N/A
2027-04-21
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
5,000 $1.44 4,038
(Direct)
View
2019-09-06
Exercise
2019-09-10
4:10 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,000 $1.24 158,767
(Direct)
View
2019-09-06
Exercise
2019-09-10
4:10 pm
2018-10-08
2024-11-04
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
19,000 $1.24 158,767
(Direct)
View
2019-10-07
Option Award
2019-10-07
7:11 pm
N/A
2029-10-07
PhaseBio Pharmaceuticals Inc PHAS Hanson Kristopher
VP
66,000 $4.17 66,000
(Direct)
View
2020-02-12
Option Award
2020-02-14
6:38 pm
N/A
2030-02-12
PhaseBio Pharmaceuticals Inc PHAS Burkhardt Glen
VP
55,000 $5.19 20,000
(Direct)
View
2020-02-12
Option Award
2020-02-14
6:38 pm
N/A
2030-02-12
PhaseBio Pharmaceuticals Inc PHAS Burkhardt Glen
VP
20,000 $5.19 20,000
(Direct)
View
2020-02-12
Option Award
2020-02-14
6:49 pm
N/A
2030-02-12
PhaseBio Pharmaceuticals Inc PHAS York Michael
VP
55,000 $5.19 55,000
(Direct)
View
2020-02-12
Option Award
2020-02-14
6:49 pm
N/A
2030-02-12
PhaseBio Pharmaceuticals Inc PHAS Sharp John P
CFO
100,000 $5.19 100,000
(Direct)
View
2020-02-12
Option Award
2020-02-14
6:50 pm
N/A
2030-02-12
PhaseBio Pharmaceuticals Inc PHAS Hanson Kristopher
VP
55,000 $5.19 55,000
(Direct)
View
2020-02-12
Option Award
2020-02-14
6:50 pm
N/A
2030-02-12
PhaseBio Pharmaceuticals Inc PHAS Sapir Alex
Director
32,000 $5.19 32,000
(Direct)
View
2020-02-12
Option Award
2020-02-14
6:50 pm
N/A
2030-02-12
PhaseBio Pharmaceuticals Inc PHAS Lee John Sang
Chief Medical Officer
100,000 $5.19 100,000
(Direct)
View
2020-02-12
Option Award
2020-02-14
6:51 pm
N/A
2030-02-12
PhaseBio Pharmaceuticals Inc PHAS Arnold Susan Elizabeth
VP
55,000 $5.19 55,000
(Direct)
View
2020-02-12
Option Award
2020-02-14
6:51 pm
N/A
2030-02-12
PhaseBio Pharmaceuticals Inc PHAS Ballance David James
VP
55,000 $5.19 55,000
(Direct)
View
2020-02-12
Option Award
2020-02-14
6:51 pm
N/A
2030-02-12
PhaseBio Pharmaceuticals Inc PHAS Mow Jonathan P
CEO
290,000 $5.19 290,000
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:39 pm
N/A
2030-06-03
PhaseBio Pharmaceuticals Inc PHAS Sapir Alex
Director
4,909 $4.86 4,909
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:52 pm
N/A
2030-06-03
PhaseBio Pharmaceuticals Inc PHAS Loewy Caroline M
Director
16,000 $0 16,000
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:55 pm
N/A
2030-06-03
PhaseBio Pharmaceuticals Inc PHAS HARRIGAN EDMUND
Director
16,000 $4.86 16,000
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:57 pm
N/A
2030-06-03
PhaseBio Pharmaceuticals Inc PHAS Hutson Nancy J
Director
16,000 $4.86 16,000
(Direct)
View
2020-06-03
Option Award
2020-06-05
6:58 pm
N/A
2030-06-03
PhaseBio Pharmaceuticals Inc PHAS van den Broek Richard
Director
16,000 $4.86 16,000
(Direct)
View
2020-06-03
Option Award
2020-06-05
7:00 pm
N/A
2030-06-03
PhaseBio Pharmaceuticals Inc PHAS Klein Peter Justin
Director
16,000 $4.86 16,000
(Direct)
View
2020-06-03
Option Award
2020-06-05
7:02 pm
N/A
2030-06-03
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director
16,000 $4.86 16,000
(Direct)
View
Goto page 0, 1, Next